Fulcrum Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Fulcrum Therapeutics Stock Summary

Fulcrum Therapeutics competes with Crinetics Pharmaceuticals, Enanta Pharmaceuticals, Amicus Therapeutics, Connect Biopharma, and Ligand Pharmaceuticals. Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Fulcrum Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 104 people.

Fulcrum Therapeutics Key Financial Ratios

Fulcrum Therapeutics Key Balance Sheet Accounts

Fulcrum Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fulcrum Therapeutics's current stock value. Our valuation model uses many indicators to compare Fulcrum Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fulcrum Therapeutics competition to find correlations between indicators driving Fulcrum Therapeutics's intrinsic value. More Info.Fulcrum Therapeutics is rated # 2 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . At present, Fulcrum Therapeutics' Return On Equity is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fulcrum Therapeutics' earnings, one of the primary drivers of an investment's value.

Fulcrum Therapeutics Systematic Risk

Today, most investors in Fulcrum Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Fulcrum Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Fulcrum Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Fulcrum Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fulcrum Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fulcrum Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Fulcrum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fulcrum Therapeutics's daily price indicators and compare them against related drivers.

When running Fulcrum Therapeutics' price analysis, check to measure Fulcrum Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulcrum Therapeutics is operating at the current time. Most of Fulcrum Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fulcrum Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulcrum Therapeutics' price. Additionally, you may evaluate how the addition of Fulcrum Therapeutics to your portfolios can decrease your overall portfolio volatility.